Consuming artificial sweeteners used in many soft drinks, including Coke Zero, could increase the risk of developing cancer, according to a study by NutriNet-Sante.
The study analyzed data of over 103,000 French people’s diet, lifestyle, and medical history from 2009 to 2021.
The participants who consumed beyond the median amount had an increased cancer risk of 13 percent compared to non-consumers, said the study's supervisor, Mathilde Touvier, who is a research director at France's INSERM institute.
According to the study, published in the journal PLOS Medicine, higher cancer risk was particularly seen with sweeteners acesulfame potassium and aspartame, both used in many soft drinks including Coke Zero.
The researchers compared sweetener consumption to the cancer rate while adjusting for other variables such as poor diet, smoking, physical activity, and age.
Women accounted for 79 percent of the participants. There was 37 percent of the total number of participants who consumed artificial sweeteners.
Soft drinks accounted for more than half of the artificial sweeteners consumed, while table-top sweeteners represented 29 percent.
The study found that "higher risks were observed for breast cancer and obesity-related cancers".
Touvier said they could not exclude biases linked to the consumers' lifestyle, calling for further research to confirm the study's results.
Millions consume sweeteners every day in products like diet soda, partly to avoid weight gain from sugar.
But these sugar substitutes have long been controversial.
However, the US National Cancer Institute and Cancer Research UK both claim that sweeteners are not cancerous, and have been authorized for use by the European Food Safety Authority.
James Brown, a biomedical scientist at Britain's Aston University, did not "believe the current study provides strong enough evidence" for Britain's National Health Service to "change its advice just yet".
According to Michael Jones of The Institute of Cancer Research, London, the link reported in the study "does not imply causation" and was "not proof that artificial sweeteners cause cancer". He added that the findings could suggest that cancer risk may be raised in the type of user rather than the sweetener.


Brent Oil Tops $100 as Middle East Conflict Threatens Supply
Oil Prices Hold Near Highs as U.S.-Iran Conflict Escalates
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
U.S. Issues Cuba Health Alert as Illnesses Rise
Japan Producer Inflation Eases to 7.6% in August
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Treasury Buyback Fails to Cool Long-Term Yields 



